Cargando…

CRISPR-based screening identifies XPO7 as a positive regulator of senescence

Detalles Bibliográficos
Autores principales:	Li, Lan-Zhu, Yang, Kuan, Jing, Yaobin, Fan, Yanling, Jiang, Xiaoyu, Wang, Si, Liu, Guang-Hui, Qu, Jing, Ma, Shuai, Zhang, Weiqi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10392025/ https://www.ncbi.nlm.nih.gov/pubmed/36897256 http://dx.doi.org/10.1093/procel/pwad012

Ejemplares similares

XPO7 is a tumor suppressor regulating p21(CIP1)-dependent senescence
por: Innes, Andrew J., et al.
Publicado: (2021)

ZKSCAN3 counteracts cellular senescence by stabilizing heterochromatin
por: Hu, Huifang, et al.
Publicado: (2020)

CRISPR-Cas9 Screening of Kaposi’s Sarcoma-Associated Herpesvirus-Transformed Cells Identifies XPO1 as a Vulnerable Target of Cancer Cells
por: Gruffaz, Marion, et al.
Publicado: (2019)

Identification of Novel Covalent XPO1 Inhibitors Based on a Hybrid Virtual Screening Strategy
por: Shen, Zheyuan, et al.
Publicado: (2022)

MAVS Antagonizes Human Stem Cell Senescence as a Mitochondrial Stabilizer
por: Wang, Cui, et al.
Publicado: (2023)

An experimental workflow for identifying RNA m(6)A alterations in cellular senescence by methylated RNA immunoprecipitation sequencing
por: Shi, Yue, et al.
Publicado: (2023)

Xpo7 is a broad-spectrum exportin and a nuclear import receptor
por: Aksu, Metin, et al.
Publicado: (2018)

Single-nucleus transcriptomics reveals a gatekeeper role for FOXP1 in primate cardiac aging
por: Zhang, Yiyuan, et al.
Publicado: (2022)

Regulation of XPO5 phosphorylation by PP2A in hepatocellular carcinoma
por: Li, Jiao, et al.
Publicado: (2022)

XPO1, therapeutic … and prognostic target in sarcomas
por: Bertucci, François, et al.
Publicado: (2016)

Large-scale chemical screen identifies Gallic acid as a geroprotector for human stem cells
por: Shan, Hezhen, et al.
Publicado: (2021)

CircXPO1 Promotes Glioblastoma Malignancy by Sponging miR-7-5p
por: Wang, Xuehui, et al.
Publicado: (2023)

A Radiosensitivity Gene Signature and XPO1 Predict Clinical Outcomes for Glioma Patients
por: Wu, Shan, et al.
Publicado: (2020)

CRISPR screen identifies CEBPB as contributor to dyskeratosis congenita fibroblast senescence via augmented inflammatory gene response
por: Westin, Erik R, et al.
Publicado: (2023)

Preclinical activity of selinexor, an inhibitor of XPO1, in sarcoma
por: Nakayama, Robert, et al.
Publicado: (2016)

Azacitidine Is Synergistically Lethal with XPO1 Inhibitor Selinexor in Acute Myeloid Leukemia by Targeting XPO1/eIF4E/c-MYC Signaling
por: Long, Huideng, et al.
Publicado: (2023)

Functional CRISPR screen identifies AP1-associated enhancer regulating FOXF1 to modulate oncogene-induced senescence
por: Han, Ruiqi, et al.
Publicado: (2018)

Genome wide CRISPR/Cas9 screen identifies the coagulation factor IX (F9) as a regulator of senescence
por: Carpintero-Fernández, Paula, et al.
Publicado: (2022)

SIRT3 consolidates heterochromatin and counteracts senescence
por: Diao, Zhiqing, et al.
Publicado: (2021)

Cocktail hepatocarcinoma therapy by a super-assembled nano-pill targeting XPO1 and ATR synergistically
por: Gong, Liuyun, et al.
Publicado: (2023)

Exosomes from antler stem cells alleviate mesenchymal stem cell senescence and osteoarthritis
por: Lei, Jinghui, et al.
Publicado: (2021)

Protein biomarkers for response to XPO1 inhibition in haematologic malignancies
por: Totiger, Tulasigeri M., et al.
Publicado: (2023)

Up-regulation of FOXD1 by YAP alleviates senescence and osteoarthritis
por: Fu, Lina, et al.
Publicado: (2019)

Correction to ‘SIRT3 consolidates heterochromatin and counteracts senescence’
por: Diao, Zhiqing, et al.
Publicado: (2021)

Simultaneous targeting of XPO1 and BCL2 as an effective treatment strategy for double-hit lymphoma
por: Liu, Yuanhui, et al.
Publicado: (2019)

Low-dose quercetin positively regulates mouse healthspan
por: Geng, Lingling, et al.
Publicado: (2019)

FTO stabilizes MIS12 and counteracts senescence
por: Zhang, Sheng, et al.
Publicado: (2022)

Association of microRNA-related gene XPO5 rs11077 polymorphism with susceptibility to thyroid cancer
por: Wen, Jing, et al.
Publicado: (2017)

XPO1 Expression Is a Poor-Prognosis Marker in Pancreatic Adenocarcinoma
por: Birnbaum, David Jérémie, et al.
Publicado: (2019)

XPO1-dependent nuclear export as a target for cancer therapy
por: Azizian, Nancy G., et al.
Publicado: (2020)

Recurrent XPO1 mutations alter pathogenesis of chronic lymphocytic leukemia
por: Walker, Janek S., et al.
Publicado: (2021)

Genome-wide CRISPR-cas9 knockout screening identifies GRB7 as a driver for MEK inhibitor resistance in KRAS mutant colon cancer
por: Yu, Chune, et al.
Publicado: (2021)

Pooled CRISPR screening identifies m(6)A as a positive regulator of macrophage activation
por: Tong, Jiyu, et al.
Publicado: (2021)

A large-scale CRISPR screen and identification of essential genes in cellular senescence bypass
por: Liu, Xuehui, et al.
Publicado: (2019)

4E-BP1 counteracts human mesenchymal stem cell senescence via maintaining mitochondrial homeostasis
por: He, Yifang, et al.
Publicado: (2022)

BMAL1 moonlighting as a gatekeeper for LINE1 repression and cellular senescence in primates
por: Liang, Chuqian, et al.
Publicado: (2022)

XPO5 promotes primary miRNA processing independently of RanGTP
por: Wang, Jingjing, et al.
Publicado: (2020)

Targeting Nuclear Exporter Protein XPO1/CRM1 in Gastric Cancer
por: Sexton, Rachel, et al.
Publicado: (2019)

Pan-cancer analysis reveals the roles of XPO1 in predicting prognosis and tumorigenesis
por: Zhao, Lei, et al.
Publicado: (2021)

The molecular mechanism and challenge of targeting XPO1 in treatment of relapsed and refractory myeloma
por: Sellin, Mark, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mq1vs1lson1bb004o44purpr0i